NSF's underlying causes remain hard to grasp

Article

The relationship between gadolinium-based contrast media for MR imaging and nephrogenic systemic fibrosis may be more nuanced than previously thought, according to several studies presented at the 2008 European Congress of Radiology.

The relationship between gadolinium-based contrast media for MR imaging and nephrogenic systemic fibrosis may be more nuanced than previously thought, according to several studies presented at the 2008 European Congress of Radiology.

Investigators at the Pitiè-Salpêtrière Hospital in Paris released data from 308 patients with renal insufficiency who underwent MRI at nine sites across France. Although nearly four-fifths of them had received a gadolinium-chelated contrast medium, none developed NSF.

Medical University of Vienna researchers reported on 552 similar cases. Their data validated previous reports on NSF prevalence but did not find a correlation between cumulative dose and agent used.

Researchers at the Glasgow Royal Infirmary in Scotland compared survival statistics from a database of 1824 patients undergoing renal replacement therapy, 14 of whom had NSF. They found the mean and median survival times for patients diagnosed with NSF were not significantly different from those of other patients (p = 0.378).

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.